SEC Form 4 · accession 0001232524-15-000115
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 12, 2015 | M | 2,073 | $46.83 | A | 50,297 | D | |
| Ordinary Shares | May 12, 2015 | S | 4,000 | $173.85 | D | 46,297 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $46.83 | May 12, 2015 | M | 2,073 | D | — | Aug 8, 2022 | Ordinary Shares | 2,073 | 46,632 | D |
Explanation of responses
- F1The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 28,137 shares and will vest with respect to 8,963 shares in equal monthly installments from June 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.